We report a case of a patient affected by epidermoid anal cancer who had hepatic progression after standard therapy with the Nigro regimen (fluorouracil and mitomycin C plus radiotherapy). This is an uncommon neoplasm against which only few chemotherapeutic agents have been tested. In our patient salvage treatment with low dose irinotecan resulted in a partial response.
KlasJ.V., RothenbergerD.A., WongW.D., MadoffRD: Malignant tumors of the anal canal. The spectrum of disease, treatment and outcomes. Cancer, 85: 1686–1693, 1999.
2.
MitchellEP: Carcinoma of the anal region. Semin Oncol, 15: 146–153, 1988.
3.
ZimmS., WamplerGL: Response of metastatic cloacogenic carcinoma to treatment with semustine. Cancer, 48: 2575–2576, 1981.
4.
SalmonR.J., ZafraniB., LabibA., AsselainB., GirodetJ: Prognosis of cloacogenic and squamous cancers of the anal canal. Dis Colon Rectum, 29: 336–340, 1986.
5.
NigroN.D., VaitkeviciusV.K., ConsidineB: Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum, 17: 354–356, 1974.
6.
JaiyesimiA., PazdurR: Cisplatin and 5FU as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal. Am J Clin Oncol, 16: 536–540, 1993.
7.
NigroN.D., VaitkeviciusV.K., ConsidineB: Dynamic management of squamous cell cancer of the anal canal. Invest. New Drugs, 7: 83–89, 1989.
FisherW.B., HerbstK.D., SimsJ.E., CritchfieldCF: Metastatic cloacogenic carcinoma of the anus: sequential responses to adriamycin and cis-dichlorodiammineplatinum. Cancer Treat Rep, 62: 91–97, 1978.
10.
SalemP.A., HabboubiN., AnaissieE., BrihiE.R., IssaP., AbbasJ.S., KhalylMF: Effectiveness of cisplatin in the treatment of anal squamous cell carcinoma. Cancer Treat Rep, 69: 891–893, 1985.
11.
KatherR., FrenayM., BourryJ., MilanoG., NamerM: Cisplatin plus 5-fluorouracil in the treatment of metastatic anal squamous cell carcinoma: a report of two cases. Cancer Treat Rep, 70: 1345–1346, 1986.
12.
CareyRW: Regression of pulmonary metastases from cloacogenic carcinoma after cisplatinum/5FU treatment. J Clin Gastroenterol, 6: 257–259, 1984.
13.
AjaniJ.A., CarrascoC.H., JacksonD.E., WallaceS: Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med, 87: 221–224, 1989.
14.
WilkingN., PetrelliN., HerreraL., MittelmanA: Phase II study of combination bleomycin, vincristine and high-dose methotrexate (BOM) with leucovorin rescue in advanced squamous cell carcinoma of the anal canal. Cancer Chemother Pharmacol, 15: 300–302, 1985.
15.
TsuruoT., MatsuzakiT., MatsushitaM., SaitoH., YokokuraT: Antitumor effect of CPT-11, a new derivative of camp-tothecin, against pleiotropic drug-resistant tumors in vitro and in vivo. Cancer Chemother Pharmacol, 21: 71–74, 1988.
16.
RothenbergML: CPT-11: an original spectrum of clinical activity. Semin Oncol, 23(1 Suppl. 3): 21–26, 1996.
